ProQR Therapeutics (PRQR) Shares Issued (2014 - 2022)

ProQR Therapeutics' Shares Issued history runs 9 years deep, the most recent figure standing at $14.4 million for Q4 2022.

• In Q4 2022, Shares Issued rose 3361.5% year-over-year to $14.4 million; the TTM figure through Dec 2022 stood at $14.4 million (down 89.16% YoY), while the FY2025 annual figure was $80319.0, down 66.29% from the prior year.
• Shares Issued came in at $14.4 million for Q4 2022 at ProQR Therapeutics, up from $37037.1 in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $99.5 million in Q2 2021 to a low of -$118.71 in Q4 2018.
• A 5-year average of $14.5 million and a median of $80700.6 in 2019 frame the typical range for Shares Issued.
• On a YoY basis, Shares Issued climbed as much as 1506388954.55% in 2018 and fell as far as 100.6% in 2018.
• ProQR Therapeutics' Shares Issued stood at -$118.71 in 2018, then soared by 25276.62% to $29886.0 in 2019, then plunged by 56.12% to $13115.2 in 2020, then soared by 3066.26% to $415261.5 in 2021, then surged by 3361.5% to $14.4 million in 2022.
• According to Business Quant data, Shares Issued over the past three periods registered $14.4 million, $37037.1, and $415261.5 for Q4 2022, Q1 2022, and Q4 2021 respectively.

Peer Comparison